E. Özer Et Al. , "BRAF V600E Mutation: A Significant Biomarker for Prediction of Disease Relapse in Pediatric Langerhans Cell Histiocytosis," PEDIATRIC AND DEVELOPMENTAL PATHOLOGY , vol.22, no.5, pp.449-455, 2019
Özer, E. Et Al. 2019. BRAF V600E Mutation: A Significant Biomarker for Prediction of Disease Relapse in Pediatric Langerhans Cell Histiocytosis. PEDIATRIC AND DEVELOPMENTAL PATHOLOGY , vol.22, no.5 , 449-455.
Özer, E., Sevinc, A., İnce, D., Yuzuguldu, R., & Olgun, N., (2019). BRAF V600E Mutation: A Significant Biomarker for Prediction of Disease Relapse in Pediatric Langerhans Cell Histiocytosis. PEDIATRIC AND DEVELOPMENTAL PATHOLOGY , vol.22, no.5, 449-455.
Özer, ERDENER Et Al. "BRAF V600E Mutation: A Significant Biomarker for Prediction of Disease Relapse in Pediatric Langerhans Cell Histiocytosis," PEDIATRIC AND DEVELOPMENTAL PATHOLOGY , vol.22, no.5, 449-455, 2019
Özer, ERDENER Et Al. "BRAF V600E Mutation: A Significant Biomarker for Prediction of Disease Relapse in Pediatric Langerhans Cell Histiocytosis." PEDIATRIC AND DEVELOPMENTAL PATHOLOGY , vol.22, no.5, pp.449-455, 2019
Özer, E. Et Al. (2019) . "BRAF V600E Mutation: A Significant Biomarker for Prediction of Disease Relapse in Pediatric Langerhans Cell Histiocytosis." PEDIATRIC AND DEVELOPMENTAL PATHOLOGY , vol.22, no.5, pp.449-455.
@article{article, author={ERDENER ÖZER Et Al. }, title={BRAF V600E Mutation: A Significant Biomarker for Prediction of Disease Relapse in Pediatric Langerhans Cell Histiocytosis}, journal={PEDIATRIC AND DEVELOPMENTAL PATHOLOGY}, year=2019, pages={449-455} }